300 related articles for article (PubMed ID: 16169856)
21. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
22. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization.
Yang N; Higuchi O; Ohashi K; Nagata K; Wada A; Kangawa K; Nishida E; Mizuno K
Nature; 1998 Jun; 393(6687):809-12. PubMed ID: 9655398
[TBL] [Abstract][Full Text] [Related]
23. Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins.
Lin T; Zeng L; Liu Y; DeFea K; Schwartz MA; Chien S; Shyy JY
Circ Res; 2003 Jun; 92(12):1296-304. PubMed ID: 12775580
[TBL] [Abstract][Full Text] [Related]
24. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
27. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
[TBL] [Abstract][Full Text] [Related]
28. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1.
Larizza L; Gervasini C; Natacci F; Riva P
Curr Mol Med; 2009 Jun; 9(5):634-53. PubMed ID: 19601812
[TBL] [Abstract][Full Text] [Related]
29. [Rho-mediated signal transduction and its physiological roles].
Ishizaki T
Nihon Yakurigaku Zasshi; 2003 Mar; 121(3):153-62. PubMed ID: 12673949
[TBL] [Abstract][Full Text] [Related]
30. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.
Mashiach-Farkash E; Rak R; Elad-Sfadia G; Haklai R; Carmeli S; Kloog Y; Wolfson HJ
Oncotarget; 2012 Jun; 3(6):629-39. PubMed ID: 22776759
[TBL] [Abstract][Full Text] [Related]
31. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.
Arber S; Barbayannis FA; Hanser H; Schneider C; Stanyon CA; Bernard O; Caroni P
Nature; 1998 Jun; 393(6687):805-9. PubMed ID: 9655397
[TBL] [Abstract][Full Text] [Related]
32. B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts.
Pritchard CA; Hayes L; Wojnowski L; Zimmer A; Marais RM; Norman JC
Mol Cell Biol; 2004 Jul; 24(13):5937-52. PubMed ID: 15199148
[TBL] [Abstract][Full Text] [Related]
33. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
36. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
[TBL] [Abstract][Full Text] [Related]
37. Dynamic compression of chondrocytes induces a Rho kinase-dependent reorganization of the actin cytoskeleton.
Haudenschild DR; D'Lima DD; Lotz MK
Biorheology; 2008; 45(3-4):219-28. PubMed ID: 18836226
[TBL] [Abstract][Full Text] [Related]
38. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1.
Yan J; Chen S; Zhang Y; Li X; Li Y; Wu X; Yuan J; Robling AG; Kapur R; Chan RJ; Yang FC
Hum Mol Genet; 2008 Apr; 17(7):936-48. PubMed ID: 18089636
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
